Novo Nordisk shares tumble as weight-loss drug trial data disappoints – Financial Times By Weight Loss Novo Nordisk shares tumble as weight-loss drug trial data disappoints Financial Times Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest